1. Home
  2. Appointments

Category: research

CréditAg names Asia research head

Crédit Agricole has hired a senior China economist from Bank of America to head up its research team for Asia ex-Japan.

Which alternatives sectors have seen a rally in secondaries pricing – and which are falling short?

Secondaries fund prices have rallied across a string of alternatives in the last quarter of 2020 according to new data from Setter Capital - but several asset classes are still feeling the pinch amid ongoing

Private capital funds must invest $5.5bn over next five years amid rising LP demand for transparency

Private capital funds must invest about $5.5bn over the next five years to meet growing demands for investor transparency, new research suggests.

TMT investment research specialist LightShed expands to VC with $75m debut fund close

TMT investment research firm LightShed Partners has branched out into venture capital investing through the close of its $75m debut fundraise.

Far from being dismissed by institutional investors amid Covid, ESG has been brought into focus by the pandemic

With the Covid-19 pandemic continuing to rage across the globe, it would be understandable to think institutional investors might have put ESG considerations to one side - but new research from bfinance seems to prove

Wealth managers planning increased PE, RE allocations in wake of Covid markets volatililty, hedge funds set to suffer

Wealth advisors are eyeing an increase of their allocation to alternative assets in the coming year following the huge market volatility of 2020, new research suggests.

Research: The future of tokenisation in alternative investments

Opalesque Industry Update - BNP Paribas Asset Management (BNPP AM), together with the Chartered Alternative Investment Analyst Association (CAIA) and Liquefy, a Hong-Kong based tokenisation platform, released a new research paper that provides key insights

VC industry scores ‘exceptional year’ for returns amid negligible Covid-19 impact

The venture capital industry scored an "exceptional" year for performance in 2020 as the effects of the global coronavirus crisis failed to bite into returns from the asset class, new research shows.

European VC brushed aside Covid chaos to score record dealmaking, fundraising totals in 2020

The European venture capital industry scored a remarkable victory in 2020 by setting new annual records for deal value and fundraising despite the volatility caused by the coronavirus crisis, new research shows.

Secondaries market set to rebound in 2021 as buyers predict record volume – Setter Capital

The global secondaries market is set to rebound to record levels this year after market volume slumped by 27% in 2020 due to the Covid-19 crisis, new research suggests.

Spanish private equity, venture capital continued breaking records last year despite Covid-19 crisis

Spanish private equity and venture capital dealmaking had record-breaking years in 2020 despite the global impact of the Covid-19 pandemic, new research shows.

NovaQuest Private Equity picks up contract development and manufacturing business CoreRx

Healthcare and life sciences investor NovaQuest Private Equity has bought contract development and manufacturing organization CoreRx.

Asia-Pacific VC focused on low-value deals amid ongoing market jitters

Asia-Pacific venture capital investors are steering clear of high-value deals in favour of seed and small Series A rounds amid huge uncertainty in the market, new research shows.

IK agrees to sell private equity research specialist Third Bridge to Astorg

IK Investment Partners has agreed to sell private equity and alternatives researcher Third Bridge to fellow buyout house Astorg.

Covid crisis supercharged VC digital health investing to record $14.8bn last year

Global venture capital funding in digital health companies surged to $14.8bn last year as the coronavirus pandemic supercharged investment into the sector.

EQT, Verdane reveal move to merge survey, market research portfolio businesses FocusVision and Confirmit

Private equity pair EQT and Verdane have revealed a planned merger of their respective portfolio companies FocusVision and Conformit.

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.